Cargando…
The Challenges of Clinical Research in Rare Cancers: Bevacizumab Use in Low-Grade Serous Ovarian and Primary Peritoneal Cancers
There are challenges to conducting rare cancer clinical trials due to issues surrounding clinical trial design, patient recruitment, and analysis of the study outcomes. This article highlights the challenges of research and data analysis in rare cancers and proposes future study directions using les...
Autores principales: | Grande, Carolyn, Visovsky, Constance, Brose, Marcia S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040873/ https://www.ncbi.nlm.nih.gov/pubmed/30018844 |
Ejemplares similares
-
The peritoneal tumour microenvironment of high-grade serous ovarian cancer
por: Leinster, D Andrew, et al.
Publicado: (2012) -
Bevacizumab Treatment for Low-Grade Serous Ovarian Cancer: A Systematic Review
por: Lazurko, Caitlin, et al.
Publicado: (2023) -
Challenges in the Conduct of Research: Chemotherapy-Induced Peripheral Neuropathy
por: Visovsky, Constance
Publicado: (2013) -
Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer
por: Auer, Katharina, et al.
Publicado: (2016) -
Concurrent Primary Peritoneal Low-Grade Serous Carcinoma and Endometrial High-Grade Serous Carcinoma
por: Lockyer, Megan G., et al.
Publicado: (2015)